Schedule 13D ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q101

Event date: 2016-10-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,134,851
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-129205
Form type
SC 13D/A
Filer
MARINUS PHARMACEUTICALS, INC.
CIK
CIK 1267813
Filed
Oct 24, 2016
Reporting period
Oct 20, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub